Risk factors for development of panel reactive antibodies and their impact on kidney transplantation outcome.
暂无分享,去创建一个
[1] M. Gnant,et al. Impact of donor age on graft function in 1180 consecutive kidney recipients. , 1991, Transplantation proceedings.
[2] J. Smit,et al. Preformed antibodies in predicting clinical renal graft outcome. , 1991, Transplantation Proceedings.
[3] L. Frödin,et al. Renal transplantation in presensitized patients treated with cyclosporine. , 1987, Transplantation Proceedings.
[4] M. R. Mickey,et al. Factors influencing kidney graft survival in the cyclosporine era: a multivariate analysis. , 1987, Transplantation proceedings.
[5] S. Vaidya,et al. Renal allograft survival in highly sensitized patients treated with cyclosporine. , 1987, Transplantation Proceedings.
[6] S. Gore,et al. Organ sharing for highly sensitized patients. , 1987, Transplantation proceedings.
[7] P. Morris,et al. RENAL TRANSPLANTATION AND B-CELL CROSS-MATCHES WITH AUTOANTIBODIES AND ALLOANTIBODIES , 1977, The Lancet.
[8] A. Sandberg,et al. Letter: A new translocation related to the Philadelphia chromosome. , 1973, Lancet.
[9] M. R. Mickey,et al. Effect of blood transfusions on subsequent kidney transplants. , 1973, Transplantation proceedings.
[10] J. V. van Hooff,et al. Efficacy of HL-A matching in Eurotransplant. , 1972, Lancet.
[11] K. Hoeffken,et al. Letter: Adriamycin in advanced breast cancer. , 1976, Lancet.